Peter Lynch fit · Growth at a reasonable price (GARP)
Is Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) a Peter Lynch Stock?
Does not fit Lynch's GARP criteria — growth too low or price too high.
28/100
FNo encaja
4/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a TEVA
PEG ≤ 1.0
clave—
EPS CAGR ≥ 15%
clave0.0%
Revenue CAGR ≥ 10%
23.9%
Net margin > 0
4.2%
Cómo se valora TEVA en otras estrategias
Datos financieros en vivo
Cap. mercado
$39.67B
PER (TTM)
25.4x
ROIC (TTM)
11.49%
Margen bruto
51.98%
Otros análisis Peter Lynch
Preguntas frecuentes
What is TEVA's Peter Lynch fit score?
TEVA scores 28/100 on our Peter Lynch fit engine — grade F. Does not fit Lynch's GARP criteria — growth too low or price too high.
Does Peter Lynch actually own TEVA?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends TEVA.
How often is this score updated?
TEVA's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende TEVA personalmente.